SCHEMBL318630

SCHEMBL318630

Cc1cc(C)c2cccnc2c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.59
SLC6A2 P23975 4/20 0.59
CCR1 P32246 3/20 0.59
CCR8 P51685 3/20 0.59
COMT P21964 1/20 0.54
KDM4E B2RXH2 8/20 0.53
HSP90AA1 P07900 6/20 0.53
TP53 P04637 5/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
TDP1 Q9NUW8 5/20 0.53
ALDH1A1 P00352 5/20 0.53
MAPT P10636 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
LMNA P02545 4/20 0.53
ALOX15 P16050 3/20 0.53
USP2 O75604 3/20 0.53
MMP14 P50281 3/20 0.53
CYP3A4 P08684 2/20 0.53
ALOX12 P18054 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17046868 1.00 HTT (0.59) HTTSLC6A2CCR1CCR8COMT
SCHEMBL29577465 1.00 HTT (0.59) HTTSLC6A2CCR1CCR8COMT
SCHEMBL1133512 0.98 HTT (0.58) HTTSLC6A2CCR1CCR8COMT
SCHEMBL8344417 0.84 HTT (0.54) HTTSLC6A2CCR1CCR8COMT
SCHEMBL22446563 0.84 L3MBTL1 (0.57) HTTSLC6A2CCR1CCR8COMT
SCHEMBL12292143 0.84 HSP90AA1 (0.72) HTTSLC6A2CCR1CCR8COMT
Tilbroquinol SCHEMBL1441958 0.84 KDM4E (0.72) HTTSLC6A2CCR1CCR8COMT
SCHEMBL8343238 0.84 HSP90AA1 (0.72) HTTSLC6A2CCR1CCR8COMT
SCHEMBL12992674 0.84 COMT (0.57) HTTSLC6A2CCR1CCR8COMT
SCHEMBL19872051 0.84 HSP90AA1 (0.72) HTTSLC6A2CCR1CCR8COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084897-A Iron ion detection reagent and preparation method and application thereof 河南省氟基新材料科技有限公司 2024-05-28 CN claimed
CN-111875555-B Synthesis method of saccharin-6-acetate 南京合创药业有限公司 2022-07-19 CN claimed
CN-111875555-A Synthesis method of saccharin-6-acetate 南京合创药业有限公司 2020-11-03 CN claimed
EP-2265677-B1 CORROSION DETECTION PRODUCT AND METHOD BATTELLE MEMORIAL INSTITUTE (US) 2019-05-15 EP claimed
CN-103221509-B Luminophor, the preparation method of luminophor and its application 波兰科学院物理化学研究所 2016-08-03 CN claimed
US-9217104-B2 Luminescent compounds, method of preparation of luminescent compounds and applications thereof INSTYTUT CHEMII FIZYCZNEJ POLSKIEJAKADEMII NAUK (PL) 2015-12-22 US claimed
CN-103787517-A Treatment method of circulating water CHINA PETROLEUM & CHEMICAL 2014-05-14 CN claimed
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO claimed
CN-118084897-A Iron ion detection reagent and preparation method and application thereof 河南省氟基新材料科技有限公司 2024-05-28 CN disclosed
US-20240148918-A1 Loading of Alginate Microspheres BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-05-09 US disclosed
EP-4301341-A1 LOADING OF ALGINATE MICROSPHERES Board of Regents, The University of Texas System (US) 2024-01-10 EP disclosed
CN-117241781-A Loading of alginate microspheres 德克萨斯大学系统董事会 2023-12-15 CN disclosed
US-11701374-B1 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression SIERRA SCIENCES, INC. (US) 2023-07-18 US disclosed
US-11701374-B1 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression SIERRA SCIENCES, INC. (US) 2023-07-18 US disclosed
EP-1328525-A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-A]INDOLE COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 2003-07-23 EP disclosed
WO-2002076994-A1 TUMOR-INHIBITING SILICON COMPOUNDS FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH (DE) 2002-10-03 WO disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed
WO-2001072752-A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 2001-10-04 WO disclosed
US-4002477-A Diffusion transfer processes and elements using or containing inert transitional metal complex oxidizing agents EASTMAN KODAK COMPANY (US) 1977-01-11 US disclosed
US-3989526-A IMAGE FORMATION, PHOTOGRAPHY EASTMAN KODAK COMPANY (US) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701374-B1 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression TERT, TERF2, RNGTT HTT 178/4885SLC6A2 2961/4885CCR1 4654/4885
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E HTT 703/4885SLC6A2 273/4885CCR1 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.